EDNRA and prostate cancer: Furthermore, activation of ETA leads to proliferation of osteoblasts, bone remodelling and release of growth factors that stimulate survival and growth of metastatic tumour cells (Nelson et al, 1999) within prostate cancer metastases in bone.